Human Cell Design
Tracked across 1 events · 6 articles · First seen Sep 09, 2026 · Last active Sep 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Revvity, Inc. (NYSE: RVTY) announced on September 9, 2026 that it has entered into a definitive agreement to acquire Human Cell Design (HCD), a France-based biotechnology company specializing in human cell models and preclinical research…
Impact: Human Cell Design is the France-based acquisition target, bringing its EndoC-betaH5 cell models and NatLine platform to a broader global customer base under Revvity ownership.
Sep 09, 2026 · 6 articles
90
Revvity entered definitive agreement Human Cell DesignRevvity Acquires Human Cell Design
ERGEN INTELLIGENCE
Track Human Cell Design live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard